Evaluating Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer With Imaging

Asia-Pacific Journal of Clinical Oncology - United Kingdom
doi 10.1111/ajco.13058
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Contemporary Use of Radium-223 in Metastatic Castration Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

Treatment of Castration-Resistant Prostate Cancer and Bone Metastases With Radium-223 Dichloride

International Journal of Urological Nursing
UrologyNursingNephrology
2014English

Pain, PSA Flare, and Bone Scan Response in a Patient With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223, a Case Report

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer

Journal of the Advanced Practitioner in Oncology
2015English

Radium-223 for the Treatment of Patients With Castration-Resistant Prostate Cancer With Bone Metastases

Medical Council
2018English

Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

Importance of the Correct Assessment of Bone Fractures in the Clinical Management of Metastatic Castration‑resistant Prostate Cancer Treated With Radium‑223: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Imaging Metastatic Castration-Resistant Prostate Cancer Patients With 89Zr-Dfo-Mstp2109a Anti-Steap1 Antibody

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy